FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 297, Issue 4, 2009, Pages

  Holloway, Graham P ^a   Jain, Swati S ^a   Bezaire, Veronic ^b   Han, Xiao Xia ^a   Glatz, Jan F C ^c   Luiken, Joost J F P ^c   Harper, Mary Ellen ^b   Bonen, Arend ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Intermyofibrillar; Muscle contraction; Subsarcolemmal

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CARNITINE; CD36 ANTIGEN; CITRATE SYNTHASE; FAT; PALMITIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; KNOCKOUT MOUSE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; UPREGULATION; WILD TYPE;

3-HYDROXYACYL COA DEHYDROGENASES; ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; CARNITINE O-PALMITOYLTRANSFERASE; CITRATE (SI)-SYNTHASE; FEMALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA, MUSCLE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OLEIC ACIDS; OXIDATION-REDUCTION; PALMITIC ACID; SUCCINIC ACID; SUCCINIMIDES;

EID: 70349623184     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.91021.2008     Document Type: Article

References (33)

1. Benton C, Holloway GP, Campbell SE, Yoshida Y, Tandon NN, Glatz JF, Luiken JJ, Spriet LL, Bonen A. Rosiglitazone increases fatty acid oxidation and fat/CD36 but not CPTI in rat muscle subsarcolemmal and intermyofibrillar mitochondria. J Physiol 586: 1755-1766, 2008.
2. Benton CR, Nickerson JG, Lally J, Han XX, Holloway GP, Glatz JF, Luiken JJ, Graham TE, Heikkila JJ, Bonen A. Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in SS, not IMF, mitochondria. J Biol Chem 283: 4228-4240, 2008.
3. Bergmeyer HU. Methods of Enzymatic Analysis. New York: Verlag Chemie Weinheim, 1974.
4. Bezaire V, Bruce CR, Heigenhauser GJ, Tandon NN, Glatz JF, Luiken JJ, Bonen A, Spriet LL. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am J Physiol Endocrinol Metab 290: E509-E515, 2006. (Pubitemid 43671698)
5. Bezaire V, Heigenhauser GJ, Spriet LL. Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscle. Am J Physiol Endocrinol Metab 286: E85-E91, 2004. (Pubitemid 38036613)
6. Bonen A, Chabowski A, Luiken JJ, Glatz JF. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology 22: 15-29, 2007.
7. Bonen A, Han XX, Habets DD, Febbraio M, Glatz JF, Luiken JJ. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am J Physiol Endocrinol Metab 292: E1740-E1749, 2007. (Pubitemid 47084709)
8. Bonen A, Luiken JJ, Liu S, Dyck DJ, Kiens B, Kristiansen S, Turcotte LP, Van Der Vusse GJ, Glatz JF. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol Endocrinol Metab 275: E471-E478, 1998. (Pubitemid 28436067)
9. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ, Dyck DJ. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18: 1144-1146, 2004. (Pubitemid 39561551)
10. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, Bonen A. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279: 36235-36241, 2004. (Pubitemid 39128959)
11. Dyck DJ, Miskovic D, Code L, Luiken JJ, Bonen A. Endurance training increases FFA oxidation and reduces triacylglycerol utilization in contracting rat soleus. Am J Physiol Endocrinol Metab 278: E778-E785, 2000. (Pubitemid 30366393)
12. Dyck DJ, Peters SJ, Glatz J, Gorski J, Keizer H, Kiens B, Liu S, Richter EA, Spriet LL, van der Vusse GJ, Bonen A. Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am J Physiol Endocrinol Metab 272: E340-E351, 1997. (Pubitemid 27148735)
13. Dyck DJ, Steinberg G, Bonen A. Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab 281: E600-E607, 2001. (Pubitemid 32880933)
14. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274: 19055-19062, 1999. (Pubitemid 129519326)
15. Habets DD, Coumans WA, Voshol PJ, den Boer MA, Febbraio M, Bonen A, Glatz JF, Luiken JJ. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem Biophys Res Commun 355: 204-210, 2007. (Pubitemid 46273388)
16. Hajri T, Abumrad NA. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 22: 383-415, 2002. (Pubitemid 35221466)
17. Holloway GP, Bezaire V, Heigenhauser GJ, Tandon NN, Glatz JF, Luiken JJ, Bonen A, Spriet LL. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J Physiol 571: 201-210, 2006.
18. King KL, Stanley WC, Rosca M, Kerner J, Hoppel CL, Febbraio M. Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36. Arch Biochem Biophys 467: 234-238, 2007. (Pubitemid 350050895)
19. Koves TR, Noland RC, Bates AL, Henes ST, Muoio DM, Cortright RN. Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. Am J Physiol Cell Physiol 288: C1074-C1082, 2005.
20. Luiken JJ, Arumugam Y, Dyck DJ, Bell RC, Pelsers MM, Turcotte LP, Tandon NN, Glatz JF, Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276: 40567-40573, 2001. (Pubitemid 37373196)
21. Luiken JJ, Koonen DP, Willems J, Zorzano A, Becker C, Fischer Y, Tandon NN, Van Der Vusse GJ, Bonen A, Glatz JF. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51: 3113-3119, 2002.
22. McGarry JD, Mills SE, Long CS, Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21-28, 1983.
23. Nickerson JG, Alkhateeb H, Benton CR, Lally J, Nickerson J, Han XX, Wilson MH, Jain SS, Snook LA, Glatz JF, Chabowski A, Luiken JJ, Bonen A. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 than FABPPM and FATP, and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J Biol Chem 284: 16522-16530, 2009.
24. Odland LM, Heigenhauser GJ, Lopaschuk GD, Spriet LL. Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. Am J Physiol Endocrinol Metab 270: E541-E544, 1996. (Pubitemid 126756385)
25. Odland LM, Howlett RA, Heigenhauser GJ, Hultman E, Spriet LL. Skeletal muscle malonyl-CoA content at the onset of exercise at varying power outputs in humans. Am J Physiol Endocrinol Metab 274: E1080-E1085, 1998. (Pubitemid 28308795)
26. Pohl J, Ring A, Korkmaz U, Ehehalt R, Stremmel W. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol Biol Cell 16: 24-31, 2005. (Pubitemid 40024287)
27. 2 solubility in aqueous media determined by a kinetic method. Anal Biochem 145: 406-418, 1985.
28. Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JF, Richter EA, Kiens B. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab 288: E133-E142, 2005. (Pubitemid 40023799)
29. Schenk S, Horowitz JF. Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training. Am J Physiol Endocrinol Metab 291: E254-E260, 2006. (Pubitemid 44035283)
30. Sebastian D, Guitart M, Garcia-Martinez C, Mauvezin C, Orellana-Gavalda JM, Serra D, Gomez-Foix AM, Hegardt FG, Asins G. Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells. J Lipid Res, doi:10.1194/jlr.M800535-JLR200, 2009.
31. Srere PA. Citrate synthase. In: Methods in Enzymology. New York: Academic, 1969.
32. Winder WW, Arogyasami J, Elayan IM, Cartmill D. Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am J Physiol Endocrinol Metab 259: E266-E271, 1990. (Pubitemid 20255721)
33. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S, Zhou B. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 82: 219-225, 1997. (Pubitemid 27052064)